drugset / Trial / NCT00073177

Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)

NCT00073177

Phase 3 Completed 819 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to compare the effects of oral roflumilast with placebo on lung function in patients with asthma.

Timeline

Start
2003-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Roflumilast Small molecule 250 ug Oral
Subject Roflumilast Small molecule 500 ug Oral

Indications